SCHEMBL3370694

SCHEMBL3370694

CC[C@@H](C)SNC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5553709 1.00
SCHEMBL3186066 1.00
Trifluoroacetic Acid SCHEMBL6511645 0.87 DPP8 (0.33)
SCHEMBL27517629 0.78 CA1 (0.46)
SCHEMBL10822864 0.77
Hydrochloric Acid SCHEMBL10822867 0.77 CYP2D6 (0.34)
SCHEMBL27730236 0.77 TDP1 (0.35)
SCHEMBL27540661 0.77 ACE2 (0.44)
SCHEMBL4770945 0.75
SCHEMBL20030568 0.74 PIK3CD (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140179711-A1 PROCESS FOR PREPARING 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDES AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2014-06-26 US disclosed
US-8680103-B2 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2014-03-25 US disclosed
US-20120302750-A1 PROCESS FOR PREPARING 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDES AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-11-29 US disclosed
US-8242270-B2 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2012-08-14 US disclosed
EP-1594854-B1 THIAZOLYL-BASED COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2010-09-01 EP disclosed
US-20090149650-A1 PROCESS FOR PREPARING 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDES AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2009-06-11 US disclosed
US-7491725-B2 purification of crystalline N-(2-chloro-6-methylphenyl)-2-(6-(4-(3-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (IV) using ethanol/water mixture; high efficiency, high yield process to get 2-aminothiazole-5-carboxamides using halogention reaction; by-products inhibition BRISTOL-MYERS SQUIBB COMPANY (US) 2009-02-17 US disclosed
US-7323482-B2 Thiazolyl-based compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2008-01-29 US disclosed
EP-1594854-A4 THIAZOLYL-BASED COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2007-07-18 EP disclosed
US-20070093537-A1 Thiazolyl-based compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY 2007-04-26 US disclosed
US-7169771-B2 Thiazolyl-based compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-01-30 US disclosed
EP-1711481-A2 PROCESS FOR PREPARING 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDES AS KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2006-10-18 EP disclosed
US-20060004067-A1 N-(2-chloro-6-methylphenyl)-2-(6-(4-(3-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide; high efficiency, high yield process to get 2-aminothiazole-5-carboxamides using halogention reaction; by-products inhibition; anticancer, psoriasis BRISTOL-MYERS SQUIBB COMPANY 2006-01-05 US disclosed
EP-1594854-A2 THIAZOLYL-BASED COMPOUNDS USEFUL AS KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2005-11-16 EP disclosed
US-20050215795-A1 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY 2005-09-29 US disclosed
WO-2005077945-A2 PROCESS FOR PREPARING 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDES AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-08-25 WO disclosed
US-20040220233-A1 Thiazolyl-based compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY 2004-11-04 US disclosed
WO-2004071440-A2 THIAZOLYL-BASED COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-08-26 WO disclosed